Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,745 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quantitative Systems Pharmacology Model of hUGT1A1-modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler-Najjar Syndrome Type 1.
Apgar JF, Tang JP, Singh P, Balasubramanian N, Burke J, Hodges MR, Lasaro MA, Lin L, Millard BL, Moore K, Jun LS, Sobolov S, Wilkins AK, Gao X. Apgar JF, et al. Among authors: moore k. CPT Pharmacometrics Syst Pharmacol. 2018 Jun;7(6):404-412. doi: 10.1002/psp4.12301. Epub 2018 Apr 26. CPT Pharmacometrics Syst Pharmacol. 2018. PMID: 29637732 Free PMC article.
The Sustained Impact of the COVID-19 Pandemic on Vascular Surgical Care Delivery.
Krafcik BM, Gladders B, Jarmel I, Moore K, Cai M, Fowler X, Suckow BD, Stone DH, Columbo JA, Davies L, Goodney PP. Krafcik BM, et al. Among authors: moore k. Ann Vasc Surg. 2024 May 28:S0890-5096(24)00244-9. doi: 10.1016/j.avsg.2024.03.025. Online ahead of print. Ann Vasc Surg. 2024. PMID: 38815917
Exosomes in diagnostic and therapeutic applications of ovarian cancer.
Bhavsar D, Raguraman R, Kim D, Ren X, Munshi A, Moore K, Sikavitsas V, Ramesh R. Bhavsar D, et al. Among authors: moore k. J Ovarian Res. 2024 May 25;17(1):113. doi: 10.1186/s13048-024-01417-0. J Ovarian Res. 2024. PMID: 38796525 Free PMC article. Review.
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study.
Landen CN, Buckanovich RJ, Sill MW, Mannel RS, Walker JL, DiSilvestro PA, Mathews CA, Mutch DG, Hernandez ML, Martin LP, Bishop E, Gill SE, Gordinier ME, Burger RA, Aghajanian C, Liu JF, Moore KN, Bookman MA. Landen CN, et al. Among authors: moore kn. J Clin Oncol. 2024 May 22:JCO2302076. doi: 10.1200/JCO.23.02076. Online ahead of print. J Clin Oncol. 2024. PMID: 38776484
4,745 results